Drag a card by its title · ⚙ to size, swap or remove

The company

MAIA Biotechnology, Inc.

MAIA · NYSE American

Health CareBiotechnologyNot moving yet

MAIA stood above a rising 150-day average in 5 of the last 52 weekly readings, and has been out of that trend for the last 33 weeks. It is 17.4% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 33
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $1.6M
Insider sales, 12 months: $0
Officials’ trades on record: 0
Institutions holding: 37 (+6)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 5 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months28

Sale orders, 12 months0

Buyers · sellers7 · 0

Who	Did	Shares	Traded
Vlad VitocChief Executive Officer	bought	73,000at $1.37	14 Sep 2026filed 15 Sep 2026
Ramiro GuerreroDirector	bought	37,595at $1.32	10 Sep 2026filed 14 Sep 2026
Ramiro GuerreroDirector	bought	46,620at $1.35	28 Aug 2026filed 1 Sep 2026
Ramiro GuerreroDirector	bought	78,239at $1.39	27 Aug 2026filed 1 Sep 2026
Ramiro GuerreroDirector	bought	8,931at $1.39	26 Aug 2026filed 1 Sep 2026
Ramiro GuerreroDirector	bought	1,794at $1.33	24 Aug 2026filed 26 Aug 2026
Ramiro GuerreroDirector	bought	11,899at $1.37	20 Aug 2026filed 24 Aug 2026
Sergei GryaznovChief Scientific Officer	bought	2,000at $1.35	1 Jun 2026filed 2 Jun 2026
Stan SmithDirector	bought	75,000at $1.34	1 Jun 2026filed 2 Jun 2026
Vlad VitocChief Executive Officer	bought	72,700at $1.39	1 Jun 2026filed 2 Jun 2026
Stan SmithDirector	bought	2,700at $3.69	19 Sep 2022filed 12 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders37+6 on the quarter

New · exited14 · 8

Reported value$19.4M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
Solas Capital Management, LLCreduced · filed 14 Aug 2026	3,030,845$4.4M	-1,266,159−29.5%
Alyeska Investment Group, L.P.unchanged · filed 14 Aug 2026	2,500,000$3.6M	00.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	2,413,270$3.5M	+339,225+16.4%
683 Capital Management, LLCunchanged · filed 14 Aug 2026	1,066,666$1.5M	00.0%
Centric Wealth Managementunchanged · filed 6 Aug 2026	796,723$1.1M	00.0%
Cable Car Capital, LPreduced · filed 14 Aug 2026	514,583$741K	-133,920−20.7%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026	504,380$727K	+143,899+39.9%
Bleichroeder LPunchanged · filed 13 Aug 2026	500,000$720K	00.0%
RENAISSANCE TECHNOLOGIES LLCnew · filed 13 Aug 2026	415,700$599K	+415,700
BlackRock, Inc.added · filed 7 Aug 2026	403,011$580K	+275,033+214.9%